To identify the main counterfeit drugs seized by the Brazilian Federal Police and the states where seizures have been made.
INTRODUCTION
Counterfeit drugs are those whose identity and/or origin have been deliberately and fraudulently altered, according to the World Health Organization (WHO). Counterfeiting encompasses reference, similar or generic products and may include products with composition similar to that of authentic products, without active components, with insuffi cient active components or with other drugs replacing the usual active agents. This practice affects both developed and developing countries and may cause loss of confi dence in the drugs, healthcare systems, healthcare professionals and pharmaceutical industry. The Federal Police has important information on seizures of counterfeit drugs in Brazil that can be compiled and organized to describe the problem of such drugs. This information is contained in the Criminalist System, which is a national database of digitized expert reports. Analysis on these data could provide a broader picture of drug counterfeiting in Brazil through data on seizures made by the Federal Police. This could make it possible to plan preventive and suppressive actions for implementation by the police and sanitary authorities.
Given the problem of drug counterfeiting, the lack of offi cial information and the diffi culty in controlling this trade, this study had the aim of identifying the drugs that are targets for counterfeiting in Brazil and the states where seizures have been made.
METHODS
This was a retrospective study using information from expert reports produced by the Federal Police. Reports on counterfeit drugs in the Federal Police's Criminalist System dated January 2007 to September 2010 were accessed. These data were produced by expert units in different Brazilian federal states.
The reports were accessed individually through the Federal Police's intranet. The following information was gathered: state in which the seizure was made; commercial name of the drug; active agent and dose indicated on the packaging; active agent and dose found in laboratory tests; and presence of other irregular drugs in the same seizure.
Data from reports in which the experts declared that the drugs were counterfeit based on visual examination, laboratory tests and consultations in the ANVISA database were included.
The information were grouped in electronic spreadsheets and organized according to pharmacological class, type of active agent and state where the seizure took place. Paraná, São Paulo and Santa Catarina were the states where the largest numbers of seizures of counterfeit drugs for treating erectile dysfunction and tests on these drugs were made (around 50.0%) (Figure 2A ). Figure 2B ). Durateston ® (Organon) and Hemogenin ® (Sanofi -Aventis), which are both anabolic steroids, contributed 8.9% and 5.7% of the seizures, respectively, and other drugs showed lower prevalences.
RESULTS

Seizures
Out of the 401 counterfeit Viagra ® and Cialis ® seizures, 372 were subjected to complete chemical tests. A large proportion of the Cialis ® samples contained the active agent sildenafi l citrate instead of tadalafi l, its original constituent ( Table 2) . Some of the samples did not present any active ingredient.
There was an increase in the number of seizures of smuggled drugs together with the counterfeit drugs: drugs against erectile dysfunction and anabolic steroids predominated (Figure 3) . Out of the 610 counterfeit drugs, 67.0% were seized together with at least one smuggled drug, thus totaling 954 smuggled drugs. The total number of smuggled drugs seized together with the drugs Cialis ® and Viagra ® was 762. Around 49.0% of the smuggled drugs were made in Paraguay.
DISCUSSION
The main counterfeit drugs seized by the Federal Police between 2007 and 2010 were drugs against erectile dysfunction and anabolic steroids. These data confi rm the information released by ANVISA that the are affected by trade in counterfeit products. The port of Santos, where such drugs may enter Brazil, is located in the state of São Paulo. Paraná is located in the region of the triple frontier (Argentina, Brazil and Paraguay), which makes it possible for these drugs to come from Paraguay, a country with a vast culture of counterfeiting foreign products, with less rigorous legislation and supervision 2,j and with lower prices. Santa Catarina has a border with Argentina, which may also be an entry route for such products.
The hypothesis that a large proportion of the counterfeit drugs seized by the Brazilian Federal Police are produced abroad and enter the country through its ports and across its borders is reinforced by the fact that a large proportion of the counterfeit drugs analyzed by the Federal Police were seized together with smuggled foreign drugs, mainly of Paraguayan origin.
counterfeit drugs with the largest number of seizures in Brazil over recent years belong to these therapeutic classes.
h This can be explained by the greater demand for these pharmaceutical groups among the Brazilian population and by their high prices.
This predominance is not replicated in countries like the United States, where the Pharmaceutical Security Institute recorded increases in counterfeiting of dietary therapeutic products (57%), anti-infection agents (48%), agents acting on the musculoskeletal system (35%), cytostatic agents (32%), agents acting on the central nervous system (28%) and agents against cardiovascular agents (23%) in 2009. Drug counterfeiting gives rise to a high sanitary risk, since no counterfeit drug is subjected to the quality and effi cacy tests required by Anvisa. Hence, for consumers, there is no certainty regarding the dose or the active ingredient involved. Such products may not produce the desired therapeutic effects and may cause unexpected clinical reactions to appear. Consequently, they worsen patients' health conditions and prolong the treatment time, thereby placing a burden on the population and public coffers.
The results from this study refl ect the real dimensions of the problem of drug counterfeiting and smuggling in Brazil, as shown by the huge increases in the number of seizures made by the Federal Police every year.
Consumption of these drugs causes enormous harm to patients and the country's public health. The suppression, supervision and education actions implemented by health regulatory agencies, police bodies and the federal government need to be expanded, with the aim of minimizing the population's access to counterfeit drugs as much as possible.
Publicity campaigns educating the public about how to identify counterfeit drugs, warning about their effects on health and emphasizing the importance of buying medications in places permitted by Anvisa need to be reinforced. There need to be increases in supervision by the bodies responsible for such actions, at the country's ports, airports and borders, as well as in pharmacies and areas of informal trade, in order to reduce the supply of these products to Brazilian consumers and to protect them from the serious problem of counterfeiting.
